RecallHawk
Class II Recall

Access Hybritech p2PSA reagent, REF B03704 and REF A49752.

Beckman Coulter, Inc.

Summary

The FDA issued a Class II for Access Hybritech p2PSA reagent, REF B03704 and REF A49752. by Beckman Coulter, Inc.. Reason: Reagent lot numbers include an insufficient concentration of blocking reagent..

Details

Source

Device Recall

External ID

Z-2043-2023

Action Date

2023-07-05

Status

Ongoing

Category

device

Product Description

Access Hybritech p2PSA reagent, REF B03704 and REF A49752.

Lot/Code Info: Lot #234320, exp. 7/31/2023, UDI (01)15099590211325(17)230731(11)220731(10)234320; Lot #234134, exp. 6/30/2023, UDI (01)15099590211325(17)230630(11)220630(10)234134; and Lot #234133, exp. 6/30/2023, UDI (01)15099590204112(17)230630(11)220630(10)234133.

Quantity Affected: 987 kits

Reason for Recall

Reagent lot numbers include an insufficient concentration of blocking reagent.

Distribution

Distribution was made to CA, CO, CT, FL, GA, IL, IN, MA, MI, NC, NE, NJ, NY, OH, SC, TN, TX, UT, and WA. There was government distribution but no military distribution. Foreign distribution was made to Australia, Austria, Belgium, Brazil, China, Czech Republic, France, Germany, Hong Kong, India, Italy, Japan, Korea, Lithuania, Macao, Mexico, Portugal, Russia, Serbia, Singapore, Slovakia, Spain, Switzerland, Taiwan, and Vietnam.

Type: Voluntary: Firm initiated

Recall Initiated: 2023-05-17

Company

Context & Analysis

This is a Class II recall. Class II recalls indicate that use of or exposure to the product may cause temporary or medically reversible health consequences, or that the probability of serious consequences is remote.

This was one of 367 device recalls issued in the same week, part of 403 device-related FDA actions this month.

Beckman Coulter, Inc. has 158 FDA actions in our database, including 111 recalls and 47 clearances.

Frequently Asked Questions

What is a Class II recall?

A Class II recall means the product may cause temporary or medically reversible adverse health consequences, or the probability of serious adverse consequences is remote. Consumers should discontinue use.

What should I do if I have this product?

Stop using the product. Check the product against the specific lot numbers or identifiers listed in the recall. Contact the manufacturer (Beckman Coulter, Inc.) or your retailer for a refund or replacement. If you experienced adverse effects, report them to the FDA via MedWatch.

How often does Beckman Coulter, Inc. have FDA actions?

Beckman Coulter, Inc. has 158 FDA actions in our database, including 111 recalls and 47 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "Z-2043-2023" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for device

Related Actions